2 Conn. firms partner to dissect C. diff genome

Wallingford, Conn.-based Shoreline Biome and Farmington, Conn.-based The Jackson Laboratory are partnering to analyze the entire collective genome of the human gut to better understand the nature of pathogenic bacteria, like Clostridium difficile, that cause thousands of hospital-acquired infections around the world.

Advertisement

“Pathogens such as C. difficile are common in hospitals and long-term care facilities, posing a major health threat,” George Weinstock, PhD, a professor with The Jackson Laboratory, said in a statement. “[W]e are developing new techniques to identify these pathogens, as well as to study the wide-ranging health effects of the multitudes of microorganisms that inhabit each of us.”

The project will use next-generation DNA sequencing to get a fuller picture of the microbiome and ultimately develop techniques for diagnosing and treating infectious disease, according to the researchers. 

More articles on infection control: 

Brazil reports first case of superbug resistant to last resort antibiotics 
UT researchers investigate ways to prevent large-scale bacterial outbreaks 
Genome researchers dive deep to differentiate dangerous Staph 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.